Clinical Trial Update: LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 clinical trial evaluated the combination of LBH589 (panobinostat) and decitabine in patients with acute myeloid leukemia or myelodysplastic syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)
• LBH589 (panobinostat) (panobinostat)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-10-13